retatrutide clinical trials review trial results 2024 2025 press release A of an investigational drug retatrutide, a novel triple agonist agent for the treatment of obesity Lilly's triple agonist, retatrutide, delivered – retatrutide trials dosage clinical trial

US$ 23.60

★★★★★ 4.8 (16 reviews)

US$ 22.59

★★★★★ 4.5 (23 reviews)

US$ 23.14

★★★★★ 4.2 (30 reviews)

US$ 23.45

★★★★★ 4.0 (15 reviews)

US$ 23.28

★★★★★ 4.4 (6 reviews)

US$ 20.01

★★★★★ 4.3 (26 reviews)

US$ 28.42

★★★★★ 4.0 (21 reviews)

US$ 26.24

★★★★★ 4.4 (11 reviews)

US$ 20.97

★★★★★ 4.9 (25 reviews)

US$ 29.31

★★★★★ 4.9 (11 reviews)

US$ 22.31

★★★★★ 4.1 (11 reviews)

US$ 23.88

★★★★★ 4.2 (29 reviews)

US$ 26.47

★★★★★ 4.0 (14 reviews)

US$ 28.38

★★★★★ 4.1 (17 reviews)

US$ 28.56

★★★★★ 5.0 (11 reviews)

US$ 25.77

★★★★★ 4.7 (10 reviews)

US$ 20.56

★★★★★ 4.4 (6 reviews)

US$ 29.74

★★★★★ 4.3 (18 reviews)

US$ 25.09

★★★★★ 4.7 (23 reviews)

US$ 20.24

★★★★★ 4.1 (17 reviews)